Capstone Therapeutics retires about 85% of convertible note principal, balance cut to $1 million

Capstone Therapeutics retired about 85% of the original $6.82 million convertible note principal via conversions, leaving about $1 million. The July 2025 note is fully retired; the October 2025 note remains outstanding.